Close
The9 Signed a Definitive Share Purchase Agreement to Invest in AI-Powered Educational Technology Company Jun 2, 2024 11:30PM

SHANGHAI, June 2, 2024 /PRNewswire/ -- The9 Limited (Nasdaq: NCTY) ("The9"), an established Internet company, today announced that it signed a definitive share purchase agreement (the "Agreement") with Wuhan Weixiang Science And Technology Co., Ltd. ("WeiXiang"), an AI-powered educational technology company in China, to purchase 19% of WeiXiang by cash and issuance of The9's restricted shares. The9 is also granted a purchase option to purchase up to 51% of the total... (continue reading...)


TOYOTA GAZOO Racing and Ogier denied in dramatic finish Jun 2, 2024 09:16PM

Toyota City, Japan, Jun 3, 2024 - (JCN Newswire) - - TOYOTA GAZOO Racing World Rally Team and Sebastien Ogier looked set to secure a third consecutive victory together at Rally Italia Sardegna before late drama in the final few kilometres of the event meant they missed out by the narrowest of margins.

Car 17 (Sebastien Ogier, Vincent Landais)

Ogier was involved in a close battle for the lead for most of the event, and while a strong Saturday afternoon enabled him to lead... (continue reading...)


AMD Unveils Next-Gen “Zen 5” Ryzen Processors to Power Advanced AI Experiences Jun 2, 2024 11:01PM

— AMD Ryzen™ AI 300 Series Processors Unlock Transformational AI Experiences for Windows Copilot+ PCs —

— AMD Ryzen™ 9000 Series Processors Set New Standards in Efficiency, Performance, and Content Creation —

TAIPEI, Taiwan, June 02, 2024 (GLOBE NEWSWIRE) -- Today, during Computex 2024, AMD (NASDAQ: AMD) announced a groundbreaking series of next-generation architecture and products aimed at ushering in a new era of AI experiences. AMD is introducing new... (continue reading...)


AMD Accelerates Pace of Data Center AI Innovation and Leadership with Expanded AMD Instinct GPU Roadmap Jun 2, 2024 11:00PM

— Updated AMD Instinct accelerator roadmap brings annual cadence of leadership AI performance and memory capabilities —

— New AMD Instinct MI325X accelerator expected to be available in Q4 2024 with up to 288GB of HBM3E memory; new AMD Instinct MI350 series accelerators based on AMD CDNA 4 architecture expected to be available in 2025 with 35x generational increase in AI inference performance —

TAIPEI, Taiwan, June 02, 2024 (GLOBE NEWSWIRE) -- At... (continue reading...)


AMD Extends AI and High-Performance Leadership in Data Center and PCs with New AMD Instinct, Ryzen and EPYC Processors at Computex 2024 Jun 2, 2024 10:59PM

— Expanded AMD Instinct accelerator roadmap brings annual cadence of leadership AI accelerators; next generation AMD EPYC processors to extend data center CPU leadership —

— New AMD Ryzen AI 300 Series laptop and AMD Ryzen 9000 Series desktop processors deliver leading performance for Copilot+ PCs, gaming, content creation and productivity —

TAIPEI, Taiwan, June 02, 2024 (GLOBE NEWSWIRE) -- Today at the Computex 2024 opening keynote, AMD (NASDAQ: AMD)... (continue reading...)


More Press Releases

View Older Stories

Jun 2, 2024 10:57PM Leads Biolabs' Innovative Cancer Treatment LBL-024, an Anti-PDL1/4-1BB Bispecific Antibody Achieved Outstanding Phase II Results, Has Been Presented in Clinical Science Symposium at 2024 ASCO Ann
Jun 2, 2024 10:51PM Appointment of Director to Woodside Board
Jun 2, 2024 10:28PM NOTICE OF THE TWENTY-FIFTH ANNUAL GENERAL MEETING OF SHAREHOLDERS
Jun 2, 2024 09:02PM Fujitsu Japan and Juntendo University launch joint research for disaster-resilient, digital medical system
Jun 2, 2024 10:15PM 2Flo Ventures Announces Addition of Renowned Life Sciences Executive Charlotte Jones-Burton, MD, MS as a Partner
Jun 2, 2024 10:13PM Flash News: OKX Launches 100% Fee Rebate Campaign
Jun 2, 2024 10:00PM Supermicro Liquid-Cooled AI SuperClusters Will Power Large-Scale AI Data Center in Japan
Jun 2, 2024 10:00PM LaVie Care Centers Takes Strategic Actions to Position the Company for Long-Term Success Amidst Challenging Skilled Nursing Operating Environment
Jun 2, 2024 09:41PM Innovent Delivers Oral Presentation of Clinical Data of A Randomized Controlled Phase 1b Study Evaluating IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab as Neoadjuvant Treatme
Jun 2, 2024 09:30PM Innovent Delivers Oral Presentations at the 2024 ASCO Annual Meeting on Clinical Data of First-in-Class anti-CLDN18.2/CD3 Bispecific Antibody (IBI389) for the Treatment of Advanced Pancreatic Cancer a
Jun 2, 2024 09:25PM SATO Technologies Corp. Reports Limited Incident at the Building Hosting Data Center One
Jun 2, 2024 09:19PM China Medical University Hospital (CMUH, Taiwan) Signs MOU with Malaysian International Medical University
Jun 2, 2024 09:14PM Keymed Biosciences Announces Long-term Efficacy and Safety Data from a Phase III Clinical Trial of Stapokibart for the Treatment of Moderate-to-severe Atopic Dermatitis
Jun 2, 2024 09:00PM TECNO exhibits its diverse smartphone and AIoT ecosystem with futuristic AR and AI products at COMPUTEX Taipei 2024, with the concept "Smart of Creation"
Jun 2, 2024 09:00PM MSI Unveils New AI and Computing Platforms with 4th Gen AMD EPYC™ Processors at Computex 2024
Jun 2, 2024 09:00PM Nissan Demonstrates Autonomous-Drive Mobility Services Progress on Public Roads
Jun 2, 2024 08:38PM Immutep Announces Clinical Collaboration with MSD to Evaluate Efti in Combination with KEYTRUDA® (pembrolizumab) in Pivotal Phase III Trial
Jun 2, 2024 08:35PM WEBTOON Entertainment Announces Public Filing of Registration Statement for Proposed Initial Public Offering
Jun 2, 2024 08:23PM Mesoblast Corporate Presentation at Investor Conference
Jun 2, 2024 08:00PM HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature Medicine
Jun 2, 2024 07:00PM Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Jun 2, 2024 07:00PM Other World Computing Introduces Intel Thunderbolt Share for the Thunderbolt Go Dock
Jun 2, 2024 06:43PM Telix Completes TLX250-CDx (Zircaix™) BLA Submission for Kidney Cancer Imaging
Jun 2, 2024 06:15PM Fast Guard Service Shares Their Experience with Local Business Owner as the Best Security Guard Company in California
Jun 2, 2024 06:01PM One in Five European Companies Are Facing Strong Pressure to Transform to Stay Viable
Jun 2, 2024 06:00PM New Blood Test Predicts Recurrence of Breast Cancer, Months or Even Years Before Relapse
Jun 2, 2024 05:30PM Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular Lymphoma
Jun 2, 2024 05:07PM Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
Jun 2, 2024 04:00PM FrogData Unveils Major AI Factory Upgrade to Revolutionize Automotive Retail Operations
Jun 2, 2024 03:45PM izmostock Unveils Revolutionary Image Solution for Leasing Industry, Driving Unparalleled ROI and User Engagement
Jun 2, 2024 03:30PM Summer Ready with Ulike Air 10: Your Smoothness Companion
Jun 2, 2024 04:07PM When Solar PV Meets Blockchain: Pse.USDT Leading the Green Energy Revolution
Jun 2, 2024 02:32PM TAGRISSO® (osimertinib) reduced the risk of disease progression or death by 84% in patients with unresectable, Stage III EGFR-mutated lung cancer vs. placebo in LAURA Phase III trial
Jun 2, 2024 12:40PM GIGABYTE Partners with NVIDIA on RTX AI PCs Supporting ACE NIM and Digital Human Technology
Jun 2, 2024 12:30PM Miami Beach Inspires this Summer with Film, Fashion and Music Experiences
Jun 2, 2024 12:30PM CatalYm Reports Impressive and Lasting Responses Including Multiple Complete Responses in Heavily Pretreated, Late- to Last-Line Metastatic NSCLC, Urothelial and Hepatocellular Cancer Patients Treated
Jun 2, 2024 12:30PM Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 2024 ASCO® Annual Meeting
Jun 2, 2024 11:32AM Rokid AR Lite Crowdfunding Surpasses $600,000 with One Day Left for Early Bird Price of $479
Jun 2, 2024 11:31AM KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
Jun 2, 2024 11:31AM KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
Jun 2, 2024 11:27AM Flash News: OKX Now Supports Wormhole Protocol's W Token on Ethereum Mainnet
Jun 2, 2024 11:27AM Flash News: OKX Now Supports Wormhole Protocol's W Token on Ethereum Mainnet
Jun 2, 2024 11:24AM Discovery of World War II fighter plane sets path for first U.S.-Papua New Guinea Sister City
Jun 2, 2024 11:00AM Linker Vision to Accelerate Vision AI Adoption Across Enterprise Applications with Large Vision Models, in Collaboration with NVIDIA
Jun 2, 2024 10:56AM Belantamab Mafodotin combination reduced the risk of disease progression or death by nearly 50% versus standard of care combination in relapsed/refractory multiple myeloma
Jun 2, 2024 10:55AM Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Early Cancer Detection Study
Jun 2, 2024 10:45AM ConcertAI to Advance Translational and Clinical Development Solutions in Collaboration with NVIDIA
Jun 2, 2024 10:40AM Boomco (BOOM) Is Now Available for Trading on LBank Exchange
Jun 2, 2024 10:25AM ASRock Rack Launches New Servers Supporting the NVIDIA Blackwell Architecture at COMPUTEX 2024
Jun 2, 2024 10:01AM Puma Biotechnology Announces Presentation of Findings from a Phase II Study of Alisertib in Endocrine-Resistant Metastatic Breast Cancer (TBCRC 041)
View Older Stories